These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15622015)

  • 21. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
    Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O;
    Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Power laws in covariability of anxiety and depression among newly diagnosed patients with major depressive episode, panic disorder and controls.
    Katerndahl DA
    J Eval Clin Pract; 2009 Jun; 15(3):565-70. PubMed ID: 19522912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mood, side of motor symptom onset and pain complaints in Parkinson's disease.
    McNamara P; Stavitsky K; Harris E; Szent-Imrey O; Durso R
    Int J Geriatr Psychiatry; 2010 May; 25(5):519-24. PubMed ID: 19711336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
    Hauser RA; McDermott MP; Messing S
    Arch Neurol; 2006 Dec; 63(12):1756-60. PubMed ID: 17172616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study.
    Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE
    Mov Disord; 2011 Feb; 26(3):484-92. PubMed ID: 21312281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.
    Ringman JM; Diaz-Olavarrieta C; Rodriguez Y; Fairbanks L; Cummings JL
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):99-105. PubMed ID: 12050472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.
    Hinkle JT; Perepezko K; Mari Z; Marsh L; Pontone GM
    Am J Geriatr Psychiatry; 2018 Jun; 26(6):700-710. PubMed ID: 29609901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden, perceived health status, and mood among caregivers of Parkinson's disease patients.
    Martinez-Martin P; Arroyo S; Rojo-Abuin JM; Rodriguez-Blazquez C; Frades B; de Pedro Cuesta J;
    Mov Disord; 2008 Sep; 23(12):1673-80. PubMed ID: 18709684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle regularity measured by the social rhythm metric in Parkinson's disease.
    Câmara Magalhães S; Vitorino Souza C; Rocha Dias T; Felipe Carvalhedo de Bruin P; de Bruin VM
    Chronobiol Int; 2005; 22(5):917-24. PubMed ID: 16298776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alexithymia and links with depression and anxiety in multiple sclerosis].
    Chahraoui K; Pinoit JM; Viegas N; Adnet J; Bonin B; Moreau T
    Rev Neurol (Paris); 2008 Mar; 164(3):242-5. PubMed ID: 18405774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of self-assessment scales for anxiety and depression in internal medicine].
    Lepine JP; Godchau M; Brun P; Teherani M
    Acta Psychiatr Belg; 1986; 86(5):608-15. PubMed ID: 3825572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.
    Leentjens AF; Dujardin K; Marsh L; Richard IH; Starkstein SE; Martinez-Martin P
    Mov Disord; 2011 Feb; 26(3):407-15. PubMed ID: 21384425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mood changes and "on-off" phenomena in Parkinson's disease.
    Menza MA; Sage J; Marshall E; Cody R; Duvoisin R
    Mov Disord; 1990; 5(2):148-51. PubMed ID: 2325676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.
    Marras C; Lang A; Krahn M; Tomlinson G; Naglie G;
    Mov Disord; 2004 Jan; 19(1):22-8. PubMed ID: 14743356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfaction and apathy in Parkinson's disease.
    Cramer CK; Friedman JH; Amick MM
    Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.